Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

Zoetis Inc. (NYSE: ZTS), the foremost global leader in animal health, is set to participate in the Bank of America Securities 2026 Animal Health Summit on February 26, 2026, at 1:15 p.m. ET. Representing the company will be Wetteny Joseph, Executive Vice President and Chief Financial Officer. Interested individuals can tune in to the live audio webcast by visiting Zoetis’ investor relations page, which will also feature a replay of the event after it concludes.

With nearly 75 years of experience, Zoetis is dedicated to improving animal health through innovative research and development, focusing on predicting, preventing, detecting, and treating animal illnesses. The company's comprehensive approach encompasses a wide range of products and services, including medications, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Zoetis serves a diverse clientele, including veterinarians, livestock producers, and pet owners across more than 100 countries.

The company’s mission is centered around nurturing both animals and humans, propelled by a commitment to innovation, scientific excellence, and a customer-centric ethos. With a vision to become the most trusted and valued name in animal health, Zoetis is continuously striving to set new benchmarks in animal care through purposeful advancements and a dedicated team.

For those looking to follow Zoetis’ journey and industry insights, they can learn more about the company and its initiatives at Zoetis.com. The upcoming summit will provide an important platform for Zoetis to showcase its contributions to animal health and further engage with stakeholders in the industry.

For additional inquiries, Zoetis has media and investor contacts available for further information regarding the event or the company's activities.

As Zoetis Inc. (NYSE: ZTS) prepares to participate in the Bank of America Securities 2026 Animal Health Summit, investors should consider the implications of this event on the company's market performance. With Wetteny Joseph, the CFO, leading the discussion, stakeholders can expect insights into Zoetis' strategic direction and innovation pipeline, which is crucial for maintaining its leadership in the animal health sector.

Zoetis has consistently demonstrated robust growth, driven by advancements in pharmaceuticals and diagnostics for animal care. The company's commitment to Research & Development (R&D) and its focus on integrating data-driven solutions position it favorably against competitors. As the global demand for pet care and livestock health continues to rise, Zoetis is well-positioned to capitalize on these trends, especially through innovative product offerings and expanding its market presence across over 100 countries.

Investment in Zoetis can be seen as a hedge against economic fluctuations. The company's diverse product portfolio, including vaccines and biopharmaceuticals, serves a broad range of clientele from veterinary practitioners to large agricultural producers. As health concerns and regulations around livestock continue to evolve, Zoetis' proactive approach could translate to strong revenue growth and profitability.

Moreover, the live audio webcast of the summit provides an opportunity for investors to gain firsthand insights into Zoetis’ future initiatives. Monitoring the company's key strategies, particularly those addressing sustainability and customer engagement will be crucial.

Given these factors, investors should consider maintaining or increasing their positions in Zoetis ahead of the summit as the event may act as a catalyst for positive market sentiment, ultimately supporting the company's growth narrative. Investors are advised to tune into the summit to better understand potential shifts in Zoetis' strategic trajectory.